According to Global Anatomic Pathology Market Size, Forecast, Analysis & Share Surpass US$ 21.2 Bn By 2026, At 6% CAGR

Anatomic Pathology Market

The global  Anatomic Pathology market accrued earnings worth approximately 16.1(USD Billion) in 2019 and is predicted to gain revenue of about 21.2(USD Billion) by 2026, is set to record a CAGR of nearly 6% over the period from 2020 to 2026. The report offers assessment and analysis of the Anatomic Pathology market on a global and regional level. The study offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2017 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Billion).


Anatomic pathology is a domain in the medical sector that deals with disease diagnosis depending upon immunologic, macroscopic, molecular, microscopic, biochemical, and molecular examining of cells, organs, and tissues. Furthermore it is one of the two branches of pathology and includes gross examination, immunohistochemistry, cytopathology, histopathology, in situ hybridization, flow immunophenotyping, and tissue Cytogenetics. Apparently, rise in the cancer cases as well as other chronic ailments along with massive research on developing effective personalized drugs will boost the expansion of anatomic pathology industry over the assessment period. In addition to this, favorable compensation policies are anticipated to result in humungous market demand over the years ahead.

Get a Free Sample :

Market Growth Dynamics

Massive dependence on biomarker-based pathological tests & methods for exploring tumorigenesis & malignancy will steer the anatomic pathology market trends. In addition to this, large-scale utilization of new pathology devices such as digital microscopes, staining equipment, and imaging tools for enhancing anatomic pathology practices will drive the business growth. Apparently, surge in the aging population prone to chronic disorders will prompt the industry expansion over 2020-2026. Additionally, escalating awareness about the significance of anatomic pathology across the globe will proliferate the anatomic pathology market size over the assessment period. Rise in the patient population base in the emerging economies as well as a steep increase in the healthcare expenditure will inflate the market value over the years to come. Nonetheless, easy access to refurbished medical products along with increase in product recalls will hinder the industry expansion over estimated timeline.

North America Market To Continue Dominance Over 2020-2026

The expansion of anatomy pathology industry in the sub-continent over 2020-2026 is due to launching of new technologies in healthcare sector and favorable government schemes for cancer testing. In addition to this, supportive compensation policies & packages for anatomic pathology tests as well as huge spending on healthcare activities will embellish the regional market trends. Furthermore, presence of strong healthcare infrastructure for clinics as well as medical labs will proliferate the expansion of anatomic pathology industry in the sub-continent over the anticipated timeline.

Directly Purchase a copy of the report with TOC @

Key players profiled in the report include: 

  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Diapath S.p.A. (Italy)
  • Bio SB (U.S.)
  • Sakura Finetek (Japan)
  • Danaher Corporation (U.S.)
  • Agilent Technologies (U.S.)
  • Hologic, Inc. (U.S.)
  • Becton
  • Dickinson and Company (U.S.)
  • PHP Holdings Corporation (Japan)  
  • Merck KGaA (Germany)
  • BioGenex Laboratories (U.S.)

The global Anatomic Pathology Market is segmented as follows:

By Products & Services

  • Instruments
  • Consumables

By Application

  • Disease Diagnosis
  • Drug Discovery & Development

By Region

  • North America
  • The U.S.
  • Canada
  • Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

Contact Us :

Rushikesh Dorge

USA : +1 347 690-0211

United Kingdom : +44 2032 894158

Japan : +81 50 5806 9039

India : +91 7768 006 007

Web :

Blog :

read other reports :

Leave a Reply

Your email address will not be published. Required fields are marked *